Mrs Versha Cheed BSc (Hons), MSc

Institute of Applied Health Research
Senior Medical Statistician

Contact details

Email
v.cheed@bham.ac.uk
View my research portal
Address
Birmingham Clinical Trials Unit (BCTU)
Institute of Applied Health Research
College of Medical and Dental Sciences
Public Health Building
University of Birmingham
Edgbaston
Birmingham
B15 2TT
UK

Versha Cheed is a Senior Statistician at the Birmingham Clinical Trials Unit (BCTU) in the Institute of Applied Health Research.

Versha works on a portfolio of clinical trials mainly in obstetrics and gynaecology as well as intraoperative care, social care and assessing medical, surgical and complex interventions.

ORCiD iD 0000-0002-6713-0913

Google Scholar Profile 

Qualifications

  • MSc in Medical Statistics, University of Leicester, 2009 
  • BSc (Hons) in Management Science, De Montfort University, 2006

Biography

Versha qualified with a First Class BSc (Hons) in Management Science from De Montfort University in 2006. In 2007, she worked for Npower as an analyst.

Versha then went on to study for an MSc in Medical Statistics at the University of Leicester and graduated in 2009. Subsequently she joined BCTU as a Trainee Medical Statistician and has progressed to Senior Medical Statistician. She is now responsible for the trial design, statistical conduct, presentation and dissemination of a diverse portfolio of RCTs.

Versha works on a portfolio of clinical trials mainly in obstetrics and gynaecology as well as intraoperative care, social care and assessing medical, surgical and complex interventions.

Teaching

  • Masters in Clinical Trials: Rationale for Clinical Trials, Key Concepts and Features
  • BCTU’s CPD approved: Introduction to Randomised Controlled Trials in Healthcare course

Other activities

Versha is part of BCTU’s public engagement working group.

As part of the working group, Versha has undertaken in:

  • Promoting the CTU as a place of work
  • Showcasing the work the CTU undertakes as well as the many roles within the organisation
  • Providing support and careers advice to school and college students
  • Participating in programmes such as ‘In-2-science’, which include a face-to-face presentation and activities to showcase the trials unit and explore careers paths with an insight into designing a trial.

Publications

Whitaker, LHR, Middleton, LJ, Daniels, JP, Williams, ARW, Priest, L, Odedra, S, Cheed, V, Stubbs, CE, Clark, TJ, Lumsden, M, Hapangama, DK, Bhattacharya, S, Smith, PP, Nicholls, EP, Roberts, N, Semple, SI, Saraswat, L, Walker, J, Chodankar, RR & Critchley, HOD 2023, 'Ulipristal acetate versus levonorgestrel-releasing intrauterine system for heavy menstrual bleeding (UCON): a randomised controlled phase III trial', EClinicalMedicine, vol. 60, pp. 101995. https://doi.org/10.1016/j.eclinm.2023.101995

Paudyal V, Lowrie R, Mair FS, Middleton L, Cheed V, Hislop J, Williamson A, Barnes N, Jolly C, Saunders K, Allen N, Jagpal P, Provan G, Ross S, Hunter C, Tearne S, McPherson A, Heath H, Lombard C, Araf A, Dixon E, Hatch A, Moir J, Akhtar S. Protocol for a pilot randomised controlled trial to evaluate integrated support from pharmacist independent prescriber and third sector worker for people experiencing homelessness: the PHOENIx community pharmacy study. Pilot Feasibility Stud. 2023 Feb 23;9(1):29. doi: 10.1186/s40814-023-01261-x. PMID: 36814302; PMCID: PMC9946705.

Sirkeci F, Moss J, Belli AM, McPherson K, Daniels J, Manyonda I, Middleton L, Cheed V, Wu O, Lumsden MA; FEMME Trial Collaborative Group. Effects on heavy menstrual bleeding and pregnancy of uterine artery embolization (UAE) or myomectomy for women with uterine fibroids wishing to avoid hysterectomy: The FEMME randomized controlled trial. Int J Gynaecol Obstet. 2023 Feb;160(2):492-501. doi: 10.1002/ijgo.14626. PMID: 36511801; PMCID: PMC10107788.

Paudyal, V., Lowrie, R., Mair, F.S. et al. Protocol for a pilot randomised controlled trial to evaluate integrated support from pharmacist independent prescriber and third sector worker for people experiencing homelessness: the PHOENIx community pharmacy study. Pilot Feasibility Stud 9, 29 (2023). https://doi.org/10.1186/s40814-023-01261-x

Gill S, Cheed V, Morton VAH, Gill D, Boelaert K, Chan S, Coomarasamy A, Dhillon-Smith RK. Evaluating the Progression to Hypothyroidism in Preconception Euthyroid Thyroid Peroxidase Antibody-Positive Women. J Clin Endocrinol Metab. 2022 Dec 17;108(1):124-134. doi: 10.1210/clinem/dgac525. PMID: 36103260.

Uterine artery embolisation versus myomectomy for premenopausal women with uterine fibroids wishing to avoid hysterectomy: the FEMME RCT. Daniels J et al; Health Technol Assess. 2022 Apr;26(22):1-74. doi: 10.3310/ZDEG6110. PMID: 35435818; PMCID: PMC9082260.

Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy: The PD MED Randomized Clinical Trial. Gray R et al; JAMA Neurol. 2022 Feb 1;79(2):131-140. doi: 10.1001/jamaneurol.2021.4736. PMID: 34962574; PMCID: PMC8715387.

Uterine artery embolization or myomectomy for women with uterine fibroids: Four-year follow-up of a randomised controlled trial. Daniels J et al; Eur J Obstet Gynecol Reprod Biol X. 2021 Nov 20;13:100139. doi: 10.1016/j.eurox.2021.100139. PMID: 34877531; PMCID: PMC8633559.

Mifepristone and misoprostol versus placebo and misoprostol for resolution of miscarriage in women diagnosed with missed miscarriage: the MifeMiso RCT. Devall A et al.  Health Technol Assess. 2021 Nov;25(68):1-114. doi: 10.3310/hta25680. PMID: 34821547.

CRT Binary Outcome Reporting Group. Completeness of reporting and risks of overstating impact in cluster randomised trials: a systematic review. Turner EL et al.  Lancet Glob Health. 2021 Aug;9(8):e1163-e1168. doi: 10.1016/S2214-109X(21)00200-X. PMID: 34297963.

Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial. Chu, J et al; The Lancet. 396, 10253, p. 770-778 9 p.

Randomised controlled trial to investigate the effectiveness of local oestrogen treatment in postmenopausal women undergoing pelvic organ prolapse surgery (LOTUS): a pilot study to assess feasibility of a large multicentre trial. Veghese, T et al; BMJ open. 10, 9, p. e025141

Uterine artery embolization or myomectomy for uterine fibroids. Mayonda, I et al; The New England Journal of Medicine. 383, 5, p. 440-451 12 p.

Pravastatin for early-onset preeclampsia: a randomized, blinded, placebo-controlled trial. Ahmed, A et al. BJOG. 2020 Mar;127(4):478-488.

Progesterone to prevent miscarriage in women with early pregnancy bleeding: the PRISM RCT. Coomarasamy A, et al. Health Technol Assess. 2020 Jun;24(33):1-70. doi: 10.3310/hta24330.

Levothyroxine to increase live births in euthyroid women with thyroid antibodies trying to conceive: the TABLET RCT. Rima K. Dhillon Smith et al. Southampton (UK): NIHR Journals Library; 2019 Oct. PMID: 31617987

Levothyroxine in Women with Thyroid Peroxidase Antibodies before Conception: the TABLET Study. Rima K. Dhillon Smith et al. N Engl J Med 2019; 380:1316-1325

A Randomized Trial of Progesterone in Women with Bleeding in Early Pregnancy: the PRISM Study. Coomarasamy, A.J et al. N Engl J Med 2019; 380:1815-1824

View all publications in research portal